HYPR
Hyperfine IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$178.32M
P/E Ratio
—
EPS
$-0.43
Beta
1.42
52W High
$2.22
52W Low
$0.53
50-Day MA
$1.22
200-Day MA
$1.21
Dividend Yield
—
Profit Margin
-262.30%
Forward P/E
—
PEG Ratio
—
About Hyperfine Inc
Hyperfine Inc. is an innovative leader in medical technology, renowned for developing the first FDA-cleared portable MRI system that revolutionizes access to imaging at the point of care. By delivering high-quality imaging directly at the bedside, Hyperfine enhances patient care and streamlines clinical decision-making, addressing the growing demand for efficient and accessible diagnostic solutions. The company's focus on cost efficiency and patient convenience uniquely positions it within the evolving healthcare landscape, making it a compelling opportunity for institutional investors seeking to invest in transformative healthcare advancements.
Fundamentals
| Revenue (TTM) | $13.56M |
| Gross Profit (TTM) | $6.75M |
| EBITDA | $-35.99M |
| Operating Margin | -144.90% |
| Return on Equity | -79.00% |
| Return on Assets | -40.60% |
| Revenue/Share (TTM) | $0.17 |
| Book Value | $0.42 |
| Price-to-Book | 4.35 |
| Price-to-Sales (TTM) | 13.15 |
| EV/Revenue | 10.58 |
| EV/EBITDA | -0.72 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 128.00% |
| Shares Outstanding | $83.47M |
| Float | $78.98M |
| % Insiders | 6.71% |
| % Institutions | 16.61% |
Historical Volatility
HV 10-Day
99.16%
HV 20-Day
77.87%
HV 30-Day
75.97%
HV 60-Day
66.83%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($2.03 target)
2
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026